CoChat

Mitochondrial antigens and autoantibodies: from anti-M1 to anti-M9

Berg, P. A., Klein, R. · 1986 · Klinische Wochenschrift

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Abstract

The specificity and clinical relevance of nine antimitochondrial antibodies (AMA) - anti-M1 to anti-M9 - are described. All nine AMA types react with antigens which are associated either with inner (M1, M2, M7) our outer mitochondrial membranes (M3, M4, M5, M6, M8, M9) derived from rat liver or beef heart mitochondria. These antigens can be clearly distinguished by their different physical and chemical properties. Anti-M1 to anti-M9 can be related to distinct clinical entities: anti-M1, anti-M5, and anti-M7 are found in nonhepatic disorders, such as syphilis (anti-M1), undefined collagen diseases (anti-M5), and some forms of cardiac diseases (anti-M7). Anti-M3 and anti-M6 are detected in drug-induced disorders, such as phenopyrazon-induced pseudolupus syndrome (PLE; anti-M3) and iproniazid-induced hepatitis (anti-M6). Anti-M2, anti-M4, anti-M8, and anti-M9 are confined to primary biliary cirrhosis (PBC). Anti-M2 is a specific marker for the diagnosis of PBC; 96% of PBC patients (n = 752) were anti-M2 positive. Anti-M4 and anti-M8 seem to reflect disease activity. Anti-M9 antibodies occur preferentially in early PBC. The clinical course of PBC was analyzed with respect to four different AMA profiles: profile A: only anti-M9 positive in the ELISA; profile B: anti-M9 and anti-M2 positive in the ELISA; profile C: anti-M2 positive in ELISA and complement fixation test (CFT), but anti-M4 and anti-M8 positive only in the ELISA; and profile D: anti-M2, anti-M4, anti-M8 positive in EL…

Overview

Integrity signals

Registry

Crossref · 10.1007/bf01728613

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 33 references

Research works printed but not linked: 3

  1. Berg PA, Traunecker U, Märker A (1973) Mitochondriale Antikörper bei nicht hepatischen Krankheiten. Dtsch Med Wochenschr 98:1186–1188
  2. Berg PA, Weber P, Oehring J, Lindenborn-Fotinos J, Stechemesser E (1985) Significance of different types of mitochondrial antibodies in primary biliary cirrhosis. In: H Brunner, H Thaler (eds) Hepatology: A Festschrift für Hans Popper. Raven press, New York, pp 231–242
  3. Klein R, Schultheiß HP, Berg PA (1984) Nachweis von organspezifischen antimitochondrialen Antikörpern (Anti-M9) bei Patienten mit primär-biliärer Zirrhose. Verh Dtsch Ges Inn Med 90:910–913

Cited by

See all 48

Metadata

Authors
Berg, P. A., & Klein, R.
Affiliations
Universitätsklinikum Tübingen (DE)
Venue
Klinische Wochenschrift
Published
1986-10
Volume
64
Issue
19
Pages
897-909
ISSN
  • 0946-2716 (ISSN-L)
  • 0023-2173
  • 1432-1440
OpenAlex
W2007048294
Cited by
48
References
33
Citations by year
2026: 3 · 2025: 2 · 2024: 1 · 2023: 4 · 2022: 4 · 2021: 1 · 2020: 3 · 2019: 2 · 2018: 3 · 2017: 3 · 2012: 2
FWCI
2.71
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Journal of Molecular Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords
antimitochondrial antibodies, anti-M2 antibodies, primary biliary cirrhosis, mitochondrial antigens, mitochondrial outer membrane, inner mitochondrial membrane, drug-induced liver injury, connective tissue diseases, syphilis, heart disease, disease activity markers, antibody profiles, cross-reactive antigens, complement fixation test
MeSH terms
Antibody Specificity, Autoantibodies, Autoantigens, Cardiolipins, Collagen Diseases, Fluorescent Antibody Technique, Humans, Liver Cirrhosis, Biliary, Lupus Erythematosus, Systemic, Mitochondria, Mitochondria, Liver, Cardiomyopathies, Myocarditis, Prognosis, Syphilis, Chemical and Drug Induced Liver Injury

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.